Genomic Medicine Expert and Biotechnology Investor Appointed to Lead Clinical Wellness Outreach Across North America
PHOENIX, AZ AND NEWPORT BEACH, CA / ACCESS Newswire / September 22, 2026 / Enyrgy Inc. has named Derrick Holman, M.D., as Medical Director, a critical role in supporting the efficacy of the Company’s Vitamin D wellness platform.
Dr. Holman will oversee the clinical questions that govern the Enyrgy Vitamin D Primal Light Platform itself: who it is suitable for, how it responds to what a user tells it, and where it defers to a person’s own physician. He will also lead Enyrgy’s direct outreach to the wellness community throughout North America.
In addition to Dr. Holman’s role as Medical Director, Enyrgy’s Scientific Advisory Board includes Dr. Samantha Kimball, who designed the dosing protocol that runs every session; Dr. Bruce Hollis, among the most cited vitamin D researchers in the world; and Dr. William Grant, a NASA UVB researcher. They each validate Enyrgy’s science.
Dr. Holman works from the science the Scientific Advisory Board validates.
Within that community, biohackers are already measuring vitamin D status, already tracking biomarkers, and already willing to add a daily protocol if the evidence supports it. Efficacy is the first of the three tenets the platform is built on, ahead of safety and usability, and Enyrgy treats it as something to keep testing rather than something already settled.
“Doctors Bruce Hollis, Samantha Kimball and Bill Grant built the protocol, and they keep us on task about what our data does and does not show,” said Scott Hansbury, co-founder and CEO of Enyrgy. “With Dr. Holman we have a genomic medicine expert who owns the clinical side of the platform itself and what belongs on the contraindication list, which is how efficacy stays a standing question rather than a settled one.”
Dr. Holman is a genomic medicine expert, entrepreneur and biotechnology investor based in Newport Beach, California, whose work spans clinical medicine, life sciences and capital formation. As managing director of Age Reversal Ventures, he evaluates and finances companies developing therapies, diagnostics and devices aimed at extending health span and addressing the biology of aging.
About Enyrgy Inc.
Enyrgy Inc. is a private health technology company in Phoenix, Arizona. Its Enyrgy Vitamin D Primal Light Platform emits over 90 percent UVB and under 10 percent UVA, verified by an independent laboratory, the inverse of natural sunlight’s roughly 95 percent UVA. A session runs two to four minutes and supports vitamin D synthesis, nitric oxide release and serotonin production. The app calculates each user’s dose from their skin type and ends the session automatically.
The platform has completed more than 25,000 sessions with a clean safety record, across more than 600 users in five countries. Enyrgy has never run paid advertising.
The return rate is under 1 percent, against an industry average of 5 to 10 percent, and the units are built in Phoenix.
Media Contact:
contact@enyrgy.com
(888) 316-1695
enyrgy.com
Enyrgy is a wellness device and is not a medical device. Enyrgy does not diagnose, treat, cure or prevent any disease. Statements regarding the Enyrgy device have not been evaluated by the Food and Drug Administration.
SOURCE: Enyrgy Inc.
View the original press release on ACCESS Newswire
Media gallery
